ole-MoiYoi O K, Pinkus G S, Spragg J, Austen K F
N Engl J Med. 1979 Jun 7;300(23):1289-94. doi: 10.1056/NEJM197906073002301.
To determine the cellular localization of glandular kallikrein in the human pancreas, immunohistochemical studies were performed with a monospecific antibody against the antigenically identical urinary kallikrein (urokallikrein). The localization of glandular pancreatic kallikrein to the beta cells of the islets was the same as that of insulin in normal human pancreas and in two islet-cell tumors. When beta cells were lacking in islet-cell tumors or in the pancreas of a patient with juvenile-onset diabetes, kallikrein antigen was not detectable. Anti-urokallikrein absorbed with purified urinary or pancreatic kallikrein no longer identified a pancreatic antigen, whereas absorption with insulin had no effect. The beta-cell localization of human pancreatic kallikrein, an endopeptidase that, in concert with carboxypeptidase B, converts bovine proinsulin to a polypeptide with the electrophoretic mobility of insulin, suggests that pancreatic kallikrein may be involved in the physiologic activation of proinsulin.
为了确定腺激肽释放酶在人胰腺中的细胞定位,使用针对抗原性相同的尿激肽释放酶(尿激肽原酶)的单特异性抗体进行了免疫组织化学研究。在正常人类胰腺和两个胰岛细胞瘤中,胰腺腺激肽释放酶在胰岛β细胞中的定位与胰岛素相同。当胰岛细胞瘤或青少年型糖尿病患者的胰腺中缺乏β细胞时,激肽释放酶抗原无法检测到。用纯化的尿或胰腺激肽释放酶吸收的抗尿激肽原酶不再识别胰腺抗原,而用胰岛素吸收则没有效果。人胰腺激肽释放酶是一种内肽酶,它与羧肽酶B协同作用,将牛胰岛素原转化为具有胰岛素电泳迁移率的多肽,其在β细胞中的定位表明胰腺激肽释放酶可能参与胰岛素原的生理激活。